Bechett's disease is a dubious disease in the field of autoimmunity and rheumatic immunity, clinical performance is complex and often involves multi-systematic stress. Early identification and standardized diagnosis are critical to improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological evaluation.
The platform can assist in matching a team of nationally and internationally authoritative experts to provide accurate diagnosis and treatment programs. Treatment and management of Bechett's disease requires individualized development of treatment programs, typically including drug therapy, rehabilitation, regular follow-up, and more. In recent years, with the development of therapeutic, immune-regulatory treatments and precision medicine, many autoimmune and rheumatic immune diseases that were previously difficult to treat have been significantly improved.
Treatment requires close monitoring of therapeutic effects and adverse reactions, adapting to timely schemes according to changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of Beckett's disease. The platform serves a team of internationally authoritative experts in the field of autoimmune and rheumatic immunity in China, providing the following services to patients: 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.